New HPAI Outbreak in Pennsylvania Threatens US Egg Market Recovery

A new HPAI outbreak in Pennsylvania threatens the fragile US egg market recovery. Supply chain vulnerability and biosecurity gaps keep egg prices structurally elevated.

New HPAI Outbreak in Pennsylvania Threatens US Egg Market Recovery
▲▲ Emerging trend or significant regional disruption

A confirmed resurgence of highly pathogenic avian influenza in a major US egg-producing state risks reversing the price declines achieved through aggressive biosecurity intervention in 2025.

The Pennsylvania outbreak is geographically contained at this stage, but HPAI has demonstrated repeatedly that it can move quickly across adjacent production regions. The egg market's structural vulnerability to supply shock has not been resolved — it has been temporarily managed.

SIGNAL

Wholesale egg prices in the United States fell from a peak of $8.53 per dozen in February 2025 to as low as $0.33 per dozen in early 2026, following a USDA biosecurity programme that included 948 farm assessments and accelerated flock repopulation support. A new HPAI outbreak has now been confirmed in commercial egg-laying operations in Pennsylvania. Industry analysts warn that even a contained outbreak in a high-density production state can rapidly tighten supply and drive prices higher.

EVIDENCE

  • Wholesale egg prices fell 64% from their February 2025 peak following USDA's biosecurity intervention programme (USDA, June 2025)
  • USDA's 2026 annual forecast projects egg prices to decline 27.4% — a projection now under active revision risk (USDA ERS)
  • Over 157 million US poultry birds have been affected by HPAI since 2022, with commercial egg-laying flocks the most consistently exposed category (USDA APHIS)

IMPLICATION

The US egg market remains structurally vulnerable to rapid price reversals driven by disease events. The Pennsylvania outbreak is a reminder that biosecurity measures reduce the probability of spread but cannot eliminate it while HPAI remains endemic in wild bird populations. Food manufacturers and foodservice operators using eggs as a core input should treat dual-sourcing and procurement flexibility as standard risk management practice, not contingency planning.

Sources: USDA ERS, USDA APHIS, Pro Farmer, USAFacts — 2025/2026

Decision Pathway GFO · Business Intelligence Layer
→  How does this move through the system?

HPAI outbreak in Pennsylvania commercial flocks → regional culling and movement restrictions → tightening US shell egg and liquid egg supply → wholesale price spike → margin compression for US food manufacturers and foodservice operators reliant on egg inputs.

⚡  Where does it hit commercially?
  • US bakery, pasta, and processed food manufacturers face immediate input cost volatility; those without contracted supply or dual-sourcing face spot market exposure at potentially 10x recent lows.
  • Foodservice chains with egg-heavy menus (breakfast QSRs, brunch concepts) in the US face margin pressure and menu repricing decisions if wholesale prices rebound toward 2025 peaks.
  • Export markets for US egg products (primarily Mexico, Canada, Japan) face supply uncertainty and potential redirection of domestic product inward.
◈  Who wins and who loses?
  • Advantaged: US producers in unaffected states (Iowa, Indiana, Ohio) with biosecure operations; Brazilian and Mexican egg exporters positioned to fill any US import demand; egg substitute manufacturers (plant-based, precision fermentation).
  • Disadvantaged: Pennsylvania egg producers facing culling and revenue loss; US food manufacturers locked into spot purchasing without hedged contracts; retailers who recently passed through price cuts now facing reversal risk.